InsiderLens
All transactionsBrowse millions of insider transactions
Top buysLargest insider purchases
Top sellsLargest insider sales
Cluster activityMultiple insiders trading together
All companiesBrowse all 22,000+ companies
ScreenerFilter by sector, country, activity
By countryBrowse by market
All InsidersBrowse all 240,000+ Insiders
Most activeInsiders with the most trades
Best performersHighest returns on insider buys
Alerts

Global search

Find a company or insider, or run a shortcut.

InsiderLens

Track insider trading activity, analyze financial data, and monitor insider transactions across global markets.

Transactions

  • Top buys
  • Top sells
  • Companies
  • Insiders
  • Screener

Resources

  • API
  • Blog
  • Help center
  • Methodology

Company

  • About
  • Contact
  • Privacy policy
  • Terms of service
  • Cookie policy

Data sources: SEC EDGAR (US) · AMF / BDIF (FR) · BaFin (DE) · FCA (GB) · FSMA (BE) · AFM (NL) · CNMV (ES) · SIX (CH) · FI (SE) · Oslo Børs (NO) · Nasdaq Nordic & Baltic · and 20+ other European regulators.

The information provided on InsiderLens is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Insider transaction data is sourced from public regulatory filings. Past insider transactions do not guarantee future performance. Always consult a qualified financial advisor before making investment decisions.

© 2026 InsiderLens

  1. Home
  2. /
  3. Insiders
  4. /
  5. Farzan Nima

Farzan Nima

BalancedHigh Signal
BoardKeros Therapeutics, Inc.·CEOKinnate Biopharma Inc.CIK 0001808296
17 transactions·2 companies·Last Jun 4, 2025
$00 buys
$00 sells
50%/50%11K shares held ≈ $120K
BOARD MEMBERatKeros Therapeutics, Inc.KROS

Last filing: Apr 2026

CEOatKinnate Biopharma Inc.KNTE

Last filing: Apr 2026

Also at Keros Therapeutics, Inc.

SJ
Seehra Jasbir
CEO23 tx
RK
Regnante Keith
CFO30 tx
LJ
Lachey Jennifer
C SUITE102 tx
RC
Rovaldi Christopher
C SUITE26 tx
OC
Ordonez Claudia
C SUITE25 tx

Insider transactions by Farzan Nima

17 transactions — - in purchases, - in sales

DateViaCompanyTypeSharesValue
Jun 4, 25DirectKROSKeros Therapeutics, Inc.Grant10 500-
Jun 4, 25DirectKROSKeros Therapeutics, Inc.Grant5 250-
May 30, 24DirectKROSKeros Therapeutics, Inc.Grant10 000-
Apr 3, 24DirectKNTEKinnate Biopharma Inc.Disposition400 000-
Apr 3, 24DirectKNTEKinnate Biopharma Inc.Disposition275 000-
Apr 3, 24DirectKNTEKinnate Biopharma Inc.Disposition750 000-
Apr 3, 24DirectKNTEKinnate Biopharma Inc.Disposition1 281 642-
Apr 3, 24DirectKNTEKinnate Biopharma Inc.Disposition437 413-
Apr 3, 24DirectKNTEKinnate Biopharma Inc.Disposition2 186-
Jun 6, 23DirectKROSKeros Therapeutics, Inc.Grant10 000-
Feb 10, 23DirectKNTEKinnate Biopharma Inc.Grant750 000-
Feb 10, 23DirectKNTEKinnate Biopharma Inc.Grant750 000-
Jun 1, 22DirectKROSKeros Therapeutics, Inc.Grant8 293-
Feb 11, 22DirectKNTEKinnate Biopharma Inc.Grant400 000-
Jun 1, 21DirectKROSKeros Therapeutics, Inc.Grant8 293-
Feb 12, 21DirectKNTEKinnate Biopharma Inc.Grant275 000-
May 29, 20DirectKROSKeros Therapeutics, Inc.Grant8 500-
Direct = personal transaction
Via entity / trust / associate

Frequently asked questions about Farzan Nima

What are Farzan Nima's recent insider transactions?

Farzan Nima has filed 17 insider transactions across 2 companies, totaling $0 in purchases and $0 in sales. The most recent filing was on June 4, 2025.

Is Farzan Nima a net buyer or seller of shares?

Based on regulatory disclosures, Farzan Nima is a net seller with 0 purchases and 0 sales on record.

Data sourced from public regulatory filings (SEC EDGAR, AMF, BaFin). This information is provided for educational purposes and does not constitute investment advice, a recommendation, or a solicitation to buy or sell securities.

Updated June 4, 2025·Full disclaimer